The company develops, manufactures, and markets bioproduction products and services for the cell and gene therapy industry, helping customers preserve biologic material and maintain cell health throughout manufacturing, distribution, and transportation. Its portfolio includes biopreservation media formulated to extend shelf-life and protect cell viability, cell processing products and closed-system containers designed for safe handling and expansion, and automated thawing devices that bring frozen biologics to liquid state in a controlled manner. The company generates revenue through direct sales and third-party distribution channels to cell and gene therapy companies and biopharma manufacturers seeking to improve product yield, reduce manufacturing risk, and bring therapies to market more reliably.